SARS-COV-2 Spike S1 Protein (D614G, His & Avi)

TargetMol Chemicals

SARS-COV-2 Spike S1 Protein (D614G, His & Avi)

16

Research Use Only

77.9 kDa (predicted). Due to glycosylation, the protein migrates to 110-120 kDa based on Tris-Bis PAGE result.

The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.

-20°C

12352200